Abstract
On March 10, 2021, our journal partnered with the Engelberg Center on Innovation Law and Policy to host a symposium addressing the role and impact of U.S. innovation policy on access to medicine. Our 2021 Symposium Issue—Volume 11, Issue 1—captures that event.This article represents the first of four panels. This panel considered what role governments should play in setting rewards for medical innovation. It was moderated by Professor Lisa Ouellette of Stanford Law School. The panelists included Professor Michael Abramowicz of George Washington University Law School, Professor Daniel Hemel of the University of Chicago Law School, and Professor Bhaven Sampat of the Columbia Mailman School of Public Health.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
